Failure to dispense a medication with a required PPI results in what labeling issue?

Failure to dispense a medication with a required PPI results in what labeling issue?

• A. Misbranded
• B. Adulterated
• C. Unsafe
• D. Recall

Answer: (A)

Omitting a required Patient Package Insert with a medication is a labeling violation because the PPI is part of the drug’s labeling information that patients rely on for safe use. When the required PPI isn’t provided, the product’s labeling is incomplete or misleading by omission, which is defined as misbranding. Misbranding can trigger enforcement actions and penalties. Adulterated refers to problems with the product’s quality, strength, or purity, not labeling. “Unsafe” isn’t a separate labeling category in itself, and a recall is an action taken in response to safety or labeling problems, not the labeling status itself.

Omitting a required Patient Package Insert with a medication is a labeling violation because the PPI is part of the drug’s labeling information that patients rely on for safe use. When the required PPI isn’t provided, the product’s labeling is incomplete or misleading by omission, which is defined as misbranding. Misbranding can trigger enforcement actions and penalties.

Adulterated refers to problems with the product’s quality, strength, or purity, not labeling. “Unsafe” isn’t a separate labeling category in itself, and a recall is an action taken in response to safety or labeling problems, not the labeling status itself.